- Other Name
- NIDDK
- Sponsors Type
- Federal/National
- Country
- United States
- Grant Types
- Fellowship/Scholarship/Dissertation Internship/Work-study Research Project Training/Course Travel Workshop/Conference Post-doctoral Collaboration/Cooperative Agreement Equipment/Facility/Organization Artistic/Exhibit/Collection Publishing/Editorial Other
- Topics
- health disparities data sharing clinical trials biomedical data science community engagement clinical metabolism collaborative research clinical trial management community health sciences health equity
Contact Info
- Address
- 9000 Rockville Pike, Bethesda, MD 20892
Last modified on 2025-09-09 19:19:54
Description
ABOUT NIDDK
NIDDK research creates knowledge about and treatments for diseases that are among the most chronic, costly, and consequential for patients, their families, and the Nation.
Sponsor Relationship
National Institute of Diabetes and Digestive and Kidney Diseases is a part of:
No sponsor in our database are part of National Institute of Diabetes and Digestive and Kidney Diseases.
Most Recent Grants from This Sponsors
Funding Opportunity Number: RFA-DK-27-125
This is a Notice of Funding Opportunity (NOFO) for a...
Added on 2026-08-31
Funding Opportunity Number: RFA-DK-27-112
This is a Notice of Funding Opportunity (NOFO) for a...
Added on 2026-08-31
Funding Opportunity Number: PAR-27-076
This is a career development program to foster the...
Added on 2026-08-31
Funding Opportunity Number: RFA-DK-27-139
This is a Notice of Funding Opportunity (NOFO) for a...
Added on 2026-08-31
Deadline Approaching Grants
Funding Opportunity Number: PAR-25-414
There is a pressing need to enhance biomedical research...
Deadline on 2026-09-28
Funding Opportunity Number: PAR-25-415
There is a pressing need to enhance biomedical research...
Deadline on 2026-09-28
Funding Opportunity Number: PAR-25-322
The purpose of the Stephen I. Katz Early Stage...
Deadline on 2026-09-28
**Funding Opportunity Number:** RFA-DK-27-119
**Category of Funding Activity:** Health ...
Deadline on 2026-09-29